Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid ...

(Billable Hours is Reuters' weekly report on lawyers and money. Please send tips or suggestions to ...

Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in ...

After a federal guilty plea in 2020, the former OxyContin drugmaker is required to reemerge from Chapter 11 bankruptcy as a ...

Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the ...

In Harrington v. Purdue Pharma L.P., the Supreme Court held that the Bankruptcy Code does not authorize a bankruptcy court to ...

The new plan allows plaintiffs who sued Purdue to opt in to receive their settlement or reserve their right to file a civil suit against the billionaire Sackler family.

Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court last year.

Purdue Pharma LP has filed a new Chapter 11 plan with the US Bankruptcy Court for the Southern District of New York, pledging ...

NEW YORK, March 19 (Reuters) - Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid settlement of at least $7.4 billion after ...

Purdue Pharma has filed a new bankruptcy plan that will distribute more than $7.4 billion to compensate opioid epidemic ...

Purdue Pharma, the pharmaceutical company responsible for OxyContin, has recently filed a new bankruptcy plan outlining a ...